Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against Oracle Corporation (ORCL); April 6, 2026, Lead Plaintiff Deadline PR Newswire
Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against Oracle Corporation (ORCL); April 6, 2026, Lead Plaintiff Deadline PR Newswire
Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against Oracle Corporation (ORCL); April 6, 2026, Lead Plaintiff Deadline Morningstar
Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against Oracle Corporation (ORCL); April 6, 2026, Lead Plaintiff Deadline Morningstar
Trustmark Corporation ( TRMK ) on Monday said that Thomas C. Owens will become Chief Operating Officer of Trustmark Bank, effective May 1, 2026. The company also said Joseph E. Bond will succeed Owens as treasurer and principal financial officer of Trustmark Corporation and as Executive VP and CFO of Trustmark Bank, effective the same date. Owens currently serves as Executive VP and CFO of Trustma...
Trustmark Corporation ( TRMK ) on Monday said that Thomas C. Owens will become Chief Operating Officer of Trustmark Bank, effective May 1, 2026. The company also said Joseph E. Bond will succeed Owens as treasurer and principal financial officer of Trustmark Corporation and as Executive VP and CFO of Trustmark Bank, effective the same date. Owens currently serves as Executive VP and CFO of Trustmark Bank. Source: Press Release More on Trustmark Trustmark Corporation (TRMK) Q4 2025 Earnings Call Transcript Trustmark Corporation 2025 Q4 - Results - Earnings Call Presentation Trustmark outlines mid-single-digit growth targets for loans and deposits in 2026 while expanding capital returns Seeking Alpha’s Quant Rating on Trustmark Historical earnings data for Trustmark
In this video, Motley Fool contributors Jason Hall and Tyler Crowe make the case for Accelerant Holdings (NYSE: ARX) and Kinsale Capital (NYSE: KNSL) as ideal stocks for smart, savvy investors to buy right now. *Stock prices used were from the afternoon of March 13, 2026. The video was published on March 30, 2026. Continue reading
In this video, Motley Fool contributors Jason Hall and Tyler Crowe make the case for Accelerant Holdings (NYSE: ARX) and Kinsale Capital (NYSE: KNSL) as ideal stocks for smart, savvy investors to buy right now. *Stock prices used were from the afternoon of March 13, 2026. The video was published on March 30, 2026. Continue reading
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on March 23, Ridgepost Capital Inc Class A's Director, David M. McCoy, invested $515,900.00 into 70,000 shares of RPC, for a cost per shar
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on March 23, Ridgepost Capital Inc Class A's Director, David M. McCoy, invested $515,900.00 into 70,000 shares of RPC, for a cost per shar
Aaround 5% of tickets will cost more than $1,000 Tickets for general public to go on sale on 9 April Tickets for the 2028 Los Angeles Olympic Games will go on sale to the general public on 9 April, organizers said on Monday, as LA28 also moved to reassure fans over ticket security by naming a group of verified resale platforms. A presale for residents in qualifying areas of Los Angeles and Oklahom...
Aaround 5% of tickets will cost more than $1,000 Tickets for general public to go on sale on 9 April Tickets for the 2028 Los Angeles Olympic Games will go on sale to the general public on 9 April, organizers said on Monday, as LA28 also moved to reassure fans over ticket security by naming a group of verified resale platforms. A presale for residents in qualifying areas of Los Angeles and Oklahoma City, which will host softball and canoe slalom events, will begin on 2 April . Continue reading...
Morsa Images/DigitalVision via Getty Images One bank that has really surprised me over the last several months now has been Origin Bancorp, Inc. ( OBK ). As a concentrated player that focuses on the valuable Sunbelt region of the U nited States , it has established for itself a history of modest growth. Most of its business involves the state of Texas, which itself is a highly desirable part of th...
Morsa Images/DigitalVision via Getty Images One bank that has really surprised me over the last several months now has been Origin Bancorp, Inc. ( OBK ). As a concentrated player that focuses on the valuable Sunbelt region of the U nited States , it has established for itself a history of modest growth. Most of its business involves the state of Texas, which itself is a highly desirable part of the nation because of low taxation and warm weather. But even with these characteristics, I ended up assigning it a "Hold" rating when I first wrote about it in June of last year. From that time through today, the stock has actually drastically outperformed the market, jumping 20% compared to the 9.6% increase that the S&P 500 saw. This is even though asset quality is disappointing and shares are trading at high multiples relative to earnings. I won't go so far as to say that it's appropriate to downgrade the company at this time. This is especially true considering some progress that the firm has made when it comes to profit margins. But if we continue to see it outperform the market like this, without a corresponding surge in profitability, a downgrade will become inevitable. Shares Are Too Pricey For My Liking The latest data that investors have access to when it comes to Origin Bancorp covers through the final quarter of the company's 2025 fiscal year . During that quarter, deposits for the institution amounted to $8.31 billion. That's actually up a bit compared to the $8.22 billion in deposits that the company had a year earlier. This rise occurred even as high-cost brokered deposits for the company dropped from $80.2 million to a big old goose egg. This means that organic deposit growth was relatively impressive, expanding by 2% year over year. Author - SEC EDGAR Data As deposits increased, other parts of the balance sheet also improved. Take loans as an example. At the end of 2024, the company had $7.48 billion worth of loans on its books. But by 2025, that number had ...
Joe Raedle/Getty Images News Although a trial of Boston Scientific's Watchman FLX Left Atrial Appendage Closure device in patients with non-valvular atrial fibrillation met primary and secondary endpoints, the company's shares closed down 9% Monday. The CHAMPION-AF study compared Watchman with oral anticoagulants. The occurrence of stroke, cardiovascular or unexplained death or systemic embolism, ...
Joe Raedle/Getty Images News Although a trial of Boston Scientific's Watchman FLX Left Atrial Appendage Closure device in patients with non-valvular atrial fibrillation met primary and secondary endpoints, the company's shares closed down 9% Monday. The CHAMPION-AF study compared Watchman with oral anticoagulants. The occurrence of stroke, cardiovascular or unexplained death or systemic embolism, the primary endpoint, was non-inferior compared to anticoagulants (5.7% vs. 4.8%). The primary safety endpoint, non-procedural major and clinically relevant non-major bleeding, was better in the Watchman cohort (10.9% vs. 19%). However, a deeper dive into the data may have concerned some investors. For example, a slightly greater portion of Watchman patients had ischemic stroke compared to those on blood thinners—3.2% to 2%. Leerink Partners' Mike Kratky, however, is remaining bullish on Boston Scientific. "In-person feedback we received from KOL [key opinion leaders] and physicians…gave us increasing confidence that these results will indeed support an uptick in WATCHMAN procedure volumes," he wrote in a note. Needham's Mike Matson is also optimistic, saying the data will help Watchman to become a first-line option for atrial fibrillation. More on Boston Scientific Boston Scientific Corporation (BSX) Presents at American College of Cardiology 75th Annual Scientific Session and Expo - Slideshow Boston Scientific Corporation (BSX) Presents at American College of Cardiology 75th Annual Scientific Session and Expo Transcript Boston Scientific: Under Pressure, But Could See A Shift In Fortunes (Rating Upgrade) Boston Scientific outlines 10% to 11% organic growth target for 2026 amid continued strength in EP and WATCHMAN Boston Scientific slips despite Q4 beat as outlook trails consensus
A man who crashed his pickup truck into a Detroit-area synagogue earlier in March was carrying out an attack inspired by the Iran-backed group Hezbollah and had sought to inflict as much damage as possible, the FBI said on Monday. Ayman Ghazali made a video before the attack at Temple Israel in West Bloomfield Township, saying he wanted to “kill as many of them as I possibly can”, said Jennifer Ru...
A man who crashed his pickup truck into a Detroit-area synagogue earlier in March was carrying out an attack inspired by the Iran-backed group Hezbollah and had sought to inflict as much damage as possible, the FBI said on Monday. Ayman Ghazali made a video before the attack at Temple Israel in West Bloomfield Township, saying he wanted to “kill as many of them as I possibly can”, said Jennifer Runyan, head of the Federal Bureau of Investigation in Detroit, who announced new information more...
Stefan Golaszewski’s exquisite new show about life after baby loss is a feat – an unsettling, funny, moving and emotionally devastating TV triumph Lisa and Stephen are good. “You good?” asks Stephen (Paapa Essiedu), plonking himself next to his wife on the sofa. “Yeah,” replies Lisa (Siobhán Cullen) from the depths of her oversize fleece hoodie. “Good,” says Stephen. “All good.” Lisa and Stephen l...
Stefan Golaszewski’s exquisite new show about life after baby loss is a feat – an unsettling, funny, moving and emotionally devastating TV triumph Lisa and Stephen are good. “You good?” asks Stephen (Paapa Essiedu), plonking himself next to his wife on the sofa. “Yeah,” replies Lisa (Siobhán Cullen) from the depths of her oversize fleece hoodie. “Good,” says Stephen. “All good.” Lisa and Stephen love each other and when Lisa has a miscarriage, then another miscarriage, they don’t talk about it, not really, because you don’t, do you? It’s just one of those things. “Gotta stay positive,” as Stephen says. “Eyes up, move forwards.” Continue reading...
You know Social Security will be there to help you cover some of your costs in retirement. But if you don't know how much it'll give you, it's difficult to work out how much you need to save on your own to cover the rest. Fortunately, you don't need to learn a complicated benefit formula or even pull out a calculator to estimate how much you might get from the program in the future. Image source: ...
You know Social Security will be there to help you cover some of your costs in retirement. But if you don't know how much it'll give you, it's difficult to work out how much you need to save on your own to cover the rest. Fortunately, you don't need to learn a complicated benefit formula or even pull out a calculator to estimate how much you might get from the program in the future. Image source: Getty Images. Continue reading
ARISA THEPBANCHORNCHAI/iStock via Getty Images I last covered Badger Meter, Inc. ( BMI ) in 2022. While I liked the company’s growth prospects, I rated it a Hold at that time, as its P/E valuation in the 40s looked too high. However, its multiple has compressed to the high 20s since then, and it is now at a more reasonable valuation at current levels. Badger Meter is a high-quality company with ~8...
ARISA THEPBANCHORNCHAI/iStock via Getty Images I last covered Badger Meter, Inc. ( BMI ) in 2022. While I liked the company’s growth prospects, I rated it a Hold at that time, as its P/E valuation in the 40s looked too high. However, its multiple has compressed to the high 20s since then, and it is now at a more reasonable valuation at current levels. Badger Meter is a high-quality company with ~85% of its sales related to replacement demand, which is largely non-discretionary and insulated from cyclicality. The company is also well positioned to benefit from the secular shift from manual meter reading to AMI. With only ~40% penetration of smart water meters in the U.S., there is a long runway for increased adoption. The company’s software offerings, like BEACON and last year’s acquisition of SmartCover, provide further avenues of growth. While the company’s organic growth is expected to slow in H1 '26 (and is weighing on current P/E multiple), the ramp-up of the Puerto Rico project should support growth acceleration in 2H26 and beyond. This should help the P/E multiple re-rate higher. The company also has good margin growth prospects with increasing software offerings and integration synergies with SmartCover helping. The stock is trading at a meaningful discount versus historical levels. I find risk-reward attractive and rate it a Buy. Revenue Analysis and Outlook In Q4 2025 , the company posted ~7.6% Y/Y op. revenue growth with 2% organic sales growth (ex SmartCover acquisition ). The utility water product business sales grew 9% Y/Y (2% Y/Y organically), driven by greater adoption of digital solutions, including ultrasonic meters, BEACON SaaS, etc. However, the flow instrumentation product business was flat Y/Y, with incremental growth in water-focused niche market applications offsetting declines across de-emphasized applications. BMI 4Q25 Sales and Operating Income (Company Data) Moving forward, I am optimistic about BMI’s revenue growth outlook. Around 85% of ...